MEDICINA
Departamento
University Medical Center Freiburg
Friburgo de Brisgovia, AlemaniaPublicaciones en colaboración con investigadores/as de University Medical Center Freiburg (15)
2024
-
Non-apoptotic FAS signaling controls mTOR activation and extrafollicular maturation in human B cells
Science Immunology, Vol. 9, Núm. 91
2023
-
Prevention and management of adverse events during treatment with bispecific antibodies and CAR T cells in multiple myeloma: a consensus report of the European Myeloma Network
The Lancet Oncology, Vol. 24, Núm. 6, pp. e255-e269
2022
-
MDS-110 SELECT-MDS-1 Trial in Progress: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of Tamibarotene/Azacitidine Versus Placebo/Azacitidine in Newly Diagnosed Adult Patients Selected for RARA-Positive Higher-Risk MDS
Clinical Lymphoma, Myeloma and Leukemia, Vol. 22, pp. S303-S304
-
Monoclonal gammopathy of renal significance (MGRS): Real-world data on outcomes and prognostic factors
American Journal of Hematology, Vol. 97, Núm. 7, pp. 877-884
2021
-
2021 European myeloma network review and consensus statement on smoldering multiple myeloma: How to distinguish (and manage) Dr. Jekyll and Mr. Hyde
Haematologica, Vol. 106, Núm. 11, pp. 2799-2812
-
COVID-19 vaccination in patients with multiple myeloma: a consensus of the European Myeloma Network
The Lancet Haematology, Vol. 8, Núm. 12, pp. e934-e946
-
Primary plasma cell leukemia: consensus definition by the International Myeloma Working Group according to peripheral blood plasma cell percentage
Blood Cancer Journal, Vol. 11, Núm. 12
-
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling study
The Lancet Haematology, Vol. 8, Núm. 3, pp. e194-e204
-
Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification—an approach to classification of patients with t-MDS
Leukemia, Vol. 35, Núm. 3, pp. 835-849
-
Toxic iron species in lower-risk myelodysplastic syndrome patients: course of disease and effects on outcome
Leukemia, Vol. 35, Núm. 6, pp. 1745-1750
2020
-
Defining persistent Staphylococcus aureus bacteraemia: secondary analysis of a prospective cohort study
The Lancet Infectious Diseases, Vol. 20, Núm. 12, pp. 1409-1417
2017
2014
-
Relevance of NcK-CD3 interaction for T cell activation in vivo
Journal of Immunology, Vol. 192, Núm. 5, pp. 2042-2053
2013
-
Molecular evidence of type 2 mosaicism in Gorlin syndrome
British Journal of Dermatology, Vol. 169, Núm. 6, pp. 1342-1345
-
Nck Recruitment to the TCR required for ZAP70 activation during thymic development
Journal of Immunology, Vol. 190, Núm. 3, pp. 1103-1112